Dergiler / European Journal of Breast Health / 2020 / Cilt: 16 - Sayı: 1

Pure Ductal Carcinoma in Situ in The Male Breast: A Rare Entity

Sayfa
77–80
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

One patient developedan invasive recurrence.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Pure ductal carcinoma in situ of male breast (DCIS) is extremely rare.
📊
Temel Bulgular & Veri:In this study, we reported 3 cases of pure ductal carcinoma in situ in the male breast.
💡
Sonuç & Katkı:One patient developedan invasive recurrence.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Pure ductal carcinoma in situ of male breast (DCIS) is extremely rare. Only a few cases have been reported until now. Its treatment is not wellestablished. Prognosis is as good as in women. In this study, we reported 3 cases of pure ductal carcinoma in situ in the male breast. The mean ageof DCIS patients was 58.3 years. The main symptom was a breast mass. The median size of the tumor was 25 mm. Two patients had an axillarylymph node. The left side was reached in 2 cases. All of the patients underwent mastectomy. The histopathological assessment showed papillary,cribriform, and comedocarcinoma in situ. There was no evidence of invasive carcinoma. In one case, the DCIS was associated with Paget'sdisease of the nipple. One patient received hormonotherapy. The time of follow-up ranged between 6 and 117 months. One patient developedan invasive recurrence.

🔖

Bu Makaleye Atıf Yap

BOUBANI, M., KAMMOUN, S., JAIDANE, O., CHARGUI, R., RAHAL, K., SAKHRI, S., ADOUNI, O. (2022). Pure Ductal Carcinoma in Situ in The Male Breast: A Rare Entity. European Journal of Breast Health, Cilt: 16 - Sayı: 1, 77–80. https://ajindex.com/articles/510767

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. Chern J, Liao L, Baraldi R, Tinney E, Hendershott K, Germaine P. Case Report: Ductal Carcinoma in Situ in the Male Breast. Case Rep Radiol 2012; 532527. (PMID: 23056988
  2. Brents M, Hancock J. Ductal Carcinoma In situ of the Male Breast. Breast Care 2016; 11: 288290. (PMID: 27721718
  3. Cutuli B, Dilhuydy JM, De Lafontan B, Berlie J, Lacroze M, Lesaunier F, Graic Y, Tortochaux J, Resbeut M, Lesimple T, Gamelin E, Campana F, Reme-Saumon M, Moncho-Bernier V, Cuilliere JC, Marchal C, De Gislain G, N’Guyen TD, Teissier E, Velten M. Ductal carcinoma in situ of the male breast. Analysis of 31 cases. Eur J Cancer 1997; 33: 3538. (PMID: 9071896
  4. Coroneos CJ, Hamm C. Ductal carcinoma in situ in a 25-year-old man presenting with apparent unilateral gynecomastia. Curr Oncol 2010; 17: 133137. (PMID: 20697526
  5. Doebar SC, Slaets L, Cardoso F, Giordano SH, Bartlett JM, Tryfonidis K, Dijkstra NH, Schröder CP, van Asperen CJ, Linderholm B, Benstead K, Dinjens WN, van Marion R, van Diest PJ, Martens JW, van Deurzen CH. Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Mod Pathol 2017; 30: 509-518. (PMID: 28084333
  6. Isley LM, Leddy RJ, Rumboldt T, Bernard JM. Asymptomatic Incidental Ductal Carcinoma in situ in a Male Breast Presenting with Contralateral Gynecomastia. J Clin Imaging Sci 2012; 2: 9. (PMID: 22530182
  7. Deutsch M, Rosenstein MM. Ductal carcinoma in situ (DCIS) of the male breast treated by lumpectomy and breast irradiation. Clin Oncol (R Coll Radiol) 1998; 10: 204-205. (PMID: 9704187
  8. Silverstein MJ, Lagios MD, Craig PH, Waisman JR, Lewinsky BS, Colburn WJ, Poller DN. A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996; 77: 2267-2274. (PMID: 8635094
  9. Silverstein, MJ. The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg 2003; 186: 337-343. (PMID: 14553846
  10. Cardoso F, Bartlett JMS, Slaets L, van Deurzen CHM, van Leeuwen-Stok E, Porter P, Linderholm B, Hedenfalk I, Schröder C7, Martens J, Bayani J, van Asperen C, Murray M, Hudis C, Middleton L, Vermeij J, Punie K, Fraser J, Nowaczyk M, Rubio IT, Aebi S, Kelly C, Ruddy KJ, Winer E, Nilsson C, Dal Lago L, Korde L, Benstead K, Bogler O, Goulioti T, Peric A, Litière S, Aalders KC, Poncet C, Tryfonidis K, Giordano SH. Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Progra